Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor

Abstract

The present invention is directed to methods of using combination therapies containing [2-({4-[(dimethylamino)iminomethyl]phenyl}carbonylamino)-5-methoxyphenyl]-N-(5-chloro(2-pyridyl))carboxamide for the treatment of thrombotic disease(s) and pharmaceutical compositions thereof.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 23, 2008
  • Application: Apr 11, 2008
    WO US 2008/0004760 W
  • Priority: Apr 13, 2007
    US US 91185207 P

Download Citation


Sign in to the Lens

Feedback